The most interesting thing about Ophir High Conviction Fund (ASX:OPH) is not one monthly return. It is the gap between the portfolio Ophir is trying to build and the price the ASX is currently putting on it.
OPH is a listed investment trust focused on Australian small and mid-cap companies outside the S&P/ASX 50. Ophir describes the fund as concentrated, long-only and built around fundamental, bottom-up research, with a bias toward quality companies exposed to structural growth opportunities.
That sounds clean on paper. In the market, it is messier.
At 31 May 2026, the fund reported a NAV unit price of A$3.11 and an ASX share price of A$2.69. That put the traded price about 13.5% below NAV, based on those disclosed figures.
The discount is the story. But it is not the whole story.
Ophir High The fund is built for a part of the market that has been hard to love
OPH does not look like an index-hugging ASX product. Its benchmark is split between the ASX Mid-Cap Accumulation Index and the ASX Small Ordinaries Accumulation Index, and the fund’s stated objective is to outperform that benchmark after fees and before tax over five years or more.
That time frame matters. Small and mid-cap investing often looks least comfortable at the point it starts getting interesting. Liquidity thins. Earnings disappointment gets punished. Fund discounts widen. The neat long-term case can look untidy for months, sometimes years.
OPH’s May update showed that tension clearly. The fund returned 6.2% for the month, ahead of the benchmark’s 1.9%. Over one year, though, the fund return was negative 6.0%, while the benchmark was positive 8.3%.
One month gave investors relief. One year still asked for patience.
The long-term record is doing heavy lifting
Since inception in August 2015, OPH reported a net return of 12.1% per annum to 31 May 2026, compared with 9.3% per annum for its benchmark. The fund also reported a total net return since inception of 243.6% on its website.
That is the number that keeps the conversation alive. A fund trading below NAV with no long-term record is a harder sell to the market. A fund trading below NAV with a decade-long record becomes a different question: is the discount signalling a broken thesis, or a period where the structure is out of favour?
The awkward answer is that both can be partly true.
The trust structure gives investors ASX access, daily liquidity and exposure to a concentrated small and mid-cap portfolio. It also means the market price can move away from NAV. That is not a technical footnote. For a listed investment trust, the entry price, the NAV and the discount or premium all matter to how investors experience returns.
The portfolio is not pretending to be broad market exposure
The May factsheet listed A2 Milk, MAAS Group, Mineral Resources, ResMed and Superloop among the top five holdings, reported alphabetically and updated quarterly. Those names span consumer staples, industrials, materials, healthcare and communications services.
That mix tells investors something useful. OPH is not a pure technology proxy, a resources proxy or a rate-cut trade. It is a manager-led portfolio where stock selection is meant to carry the outcome.
Ophir’s own commentary points to that selective stance. The manager said its focus remained on reasonably valued small-cap businesses with earnings growth, while keeping a balanced mix of cyclical and defensive exposure and a tilt toward less macro-sensitive companies.
The fund is asking investors to judge the process, not just the category.
The pressure sits in the discount, the fees and the cycle
There are three pressure points investors may watch.
The first is the OPH discount to NAV. A discount can narrow and help unit-price returns. It can also persist, particularly when small-cap funds are out of favour or investors prefer larger, more liquid exposures.
The second is fees. The fund discloses management fees and costs of 1.20% per annum plus ordinary expenses, with a performance fee of 20% per annum of outperformance, subject to a high-water mark.
The third is the small-cap cycle itself. Ophir said Australian small caps continued to trade at a large valuation discount to the ASX 50 on a forward price-earnings basis, which supported its outlook. That may be right, but valuation gaps can stay open longer than expected.
The next test is simple enough. OPH needs the portfolio’s longer-term record to reassert itself, the small-cap backdrop to stop working against it, and the listed price to close some of the gap with NAV. Until then, the fund remains a study in patience, not a clean verdict.
